ET Wealth collaborates with Value Research to analyse top mutual funds. We examine the key fundamentals of the fund, its portfolio and performance to help you make an informed investment decision.

BASIC FACTS
DATE OF LAUNCH

4 JUL 2004

CATEGORY

EQUITY

TYPE

MID CAP

AUM*

Rs.7,348 crore

BENCHMARK

NIFTY MIDCAP 150

TOTAL RETURN INDEX

WHAT IT COSTS
NAV**

GROWTH OPTION

Rs.194.84

IDCW

Rs.92.20

MINIMUM INVESTMENT

Rs.5,000

MINIMUM SIP AMOUNT

Rs.500

EXPENSE RATIO*** (%)

1.78

EXIT LOAD

1% for redemption

within 364 days

*AS ON 31 OCTOBER 2022
**AS ON 6 DECEMBER 2022
***AS ON 31 OCTOBER 2022

FUND MANAGER

ANKIT AGARWAL

TENURE: 3 YEARS, 3 MONTHS

Recent portfolio changes
New Entrants: Aarti Pharmalabs, The Ramco Cements.

Complete Exits: NA

Increasing allocation: Bharat Electronics, Dr. Lal Pathlabs, Jubilant FoodWorks, PB Fintech, Sundram Fasteners, Syngene International, United Breweries (Sept), Alkem Labs, Balkrishna Inds, Dr. Lal Pathlabs, Honeywell Automation, PB Fintech, Prestige Estates, Sundram Fasteners, United Breweries (Oct)

Should you buy?

This mid cap fund runs a blend of growth and value investing style with a tilt towards growth. Its preference is for businesses with scalable models with long growth runway but remains open for companies going through transitory phase of weakness or transformational change. The portfolio is heavily diversified with modest positions even in top bets. It is sector agnostic and retains flexibility to stay invested in stocks growing into large caps. The fund’s performance has slipped visibly in recent years. While it retains a healthy risk-return profile, it must plug the gap with index and peers quickly to remain a good pick.

(Source: Value Research)